Publication:
CD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death.

dc.contributor.authorPera, Alejandra
dc.contributor.authorCaserta, Stefano
dc.contributor.authorAlbanese, Fabio
dc.contributor.authorBlowers, Pinar
dc.contributor.authorMorrow, George
dc.contributor.authorTerrazzini, Nadia
dc.contributor.authorSmith, Helen E
dc.contributor.authorRajkumar, Chakravarthi
dc.contributor.authorReus, Bernhard
dc.contributor.authorMsonda, James R
dc.contributor.authorVerboom, Murielle
dc.contributor.authorHallensleben, Michael
dc.contributor.authorBlasczyk, Rainer
dc.contributor.authorDavies, Kevin A
dc.contributor.authorKern, Florian
dc.contributor.funderThe Dunhill Medical Trust
dc.date.accessioned2023-01-25T10:22:08Z
dc.date.available2023-01-25T10:22:08Z
dc.date.issued2018-07-18
dc.description.abstractAn increased risk of cardiovascular death in Cytomegalovirus (CMV)-infected individuals remains unexplained, although it might partly result from the fact that CMV infection is closely associated with the accumulation of CD28null T-cells, in particular CD28null CD4 T-cells. These cells can directly damage endothelium and precipitate cardiovascular events. However, the current paradigm holds that the accumulation of CD28null T-cells is a normal consequence of aging, whereas the link between these T-cell populations and CMV infection is explained by the increased prevalence of this infection in older people. Resolving whether CMV infection or aging triggers CD28null T-cell expansions is of critical importance because, unlike aging, CMV infection can be treated. Methods: We used multi-color flow-cytometry, antigen-specific activation assays, and HLA-typing to dissect the contributions of CMV infection and aging to the accumulation of CD28null CD4 and CD8 T-cells in CMV+ and CMV- individuals aged 19 to 94 years. Linear/logistic regression was used to test the effect of sex, age, CMV infection, and HLA-type on CD28null T-cell frequencies. Results: The median frequencies of CD28null CD4 T-cells and CD28null CD8 T-cells were >12-fold (p=0.000) but only approximately 2-fold higher (p=0.000), respectively, in CMV+ (n=136) compared with CMV- individuals (n=106). The effect of CMV infection on these T-cell subsets was confirmed by linear regression. Unexpectedly, aging contributed only marginally to an increase in CD28null T-cell frequencies, and only in CMV+ individuals. Interestingly, the presence of HLA-DRB1*0301 led to an approximately 9-fold reduction of the risk of having CD28null CD4 T-cell expansions (OR=0.108, p=0.003). Over 75% of CMV-reactive CD4 T-cells were CD28null. Conclusion: CMV infection and HLA type are major risk factors for CD28null CD4 T-cell-associated cardiovascular pathology. Increased numbers of CD28null CD8 T-cells are also associated with CMV infection, but to a lesser extent. Aging, however, makes only a negligible contribution to the expansion of these T-cell subsets, and only in the presence of CMV infection. Our results open up new avenues for risk assessment, prevention, and treatment.
dc.description.versionSi
dc.identifier.citationPera A, Caserta S, Albanese F, Blowers P, Morrow G, Terrazzini N, et al. CD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death. Theranostics. 2018 Aug 7;8(16):4509-4519
dc.identifier.doi10.7150/thno.27428
dc.identifier.essn1838-7640
dc.identifier.pmcPMC6134924
dc.identifier.pmid30214635
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134924/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.7150/thno.27428
dc.identifier.urihttp://hdl.handle.net/10668/12942
dc.issue.number16
dc.journal.titleTheranostics
dc.language.isoen
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.organizationHospital Universitario Reina Sofía
dc.page.number4509-4519
dc.provenanceRealizada la curación de contenido 08/08/2024
dc.publisherIvyspring International Publisher
dc.pubmedtypeJournal Article
dc.relation.projectIDR278/0213
dc.relation.projectIDR107/0209
dc.relation.publisherversionhttps://www.thno.org/v08p4509.htm
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCD28null CD4 T-cells
dc.subjectCD28null CD8 T-cells
dc.subjectCytomegalovirus
dc.subjectAging
dc.subjectCardiovascular disease
dc.subjectCoronary complications
dc.subject.decsAntígenos CD28
dc.subject.decsCitometría de flujo
dc.subject.decsEnvejecimiento
dc.subject.decsFactores de riesgo
dc.subject.decsInfecciones por Citomegalovirus
dc.subject.decsInsuficiencia cardíaca
dc.subject.decsLinfocitos T CD4-positivos
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAging
dc.subject.meshCD28 antigens
dc.subject.meshCD4-positive T-lymphocytes
dc.subject.meshCytomegalovirus infections
dc.subject.meshFemale
dc.subject.meshFlow cytometry
dc.subject.meshHeart failure
dc.subject.meshHistocompatibility testing
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshPrevalence
dc.subject.meshRisk factors
dc.subject.meshYoung adult
dc.titleCD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number8
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC6134924.pdf
Size:
2.17 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Pera_CD28null_MaterialSuplementario.pdf
Size:
967.2 KB
Format:
Adobe Portable Document Format